These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 28604704)

  • 41. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
    Jeftic I; Jovicic N; Pantic J; Arsenijevic N; Lukic ML; Pejnovic N
    Mol Med; 2015 May; 21(1):453-65. PubMed ID: 26018806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction.
    Cheng C; Tan J; Qian W; Zhang L; Hou X
    Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel role of TLR4 in NAFLD development: Modulation of metabolic enzymes expression.
    Ferreira DF; Fiamoncini J; Prist IH; Ariga SK; de Souza HP; de Lima TM
    Biochim Biophys Acta; 2015 Oct; 1851(10):1353-9. PubMed ID: 26172853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.
    Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
    Nutr Res; 2015 May; 35(5):449-59. PubMed ID: 25934114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
    Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
    Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salicornia Extract Ameliorates Salt-Induced Aggravation of Nonalcoholic Fatty Liver Disease in Obese Mice Fed a High-Fat Diet.
    Kim JH; Suk S; Jang WJ; Lee CH; Kim JE; Park JK; Kweon MH; Kim JH; Lee KW
    J Food Sci; 2017 Jul; 82(7):1765-1774. PubMed ID: 28608557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice.
    Li P; Yan K; Chang X; Chen X; Wang R; Fan X; Tang T; Zhan D; Qi K
    Gut Microbes; 2020 Nov; 11(6):1590-1607. PubMed ID: 32576050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.
    Benbow JH; Thompson KJ; Cope HL; Brandon-Warner E; Culberson CR; Bossi KL; Li T; Russo MW; Gersin KS; McKillop IH; deLemos AS; Schrum LW
    Am J Pathol; 2016 Jan; 186(1):145-58. PubMed ID: 26603137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease.
    Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X
    Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice.
    Ye D; Li FY; Lam KS; Li H; Jia W; Wang Y; Man K; Lo CM; Li X; Xu A
    Gut; 2012 Jul; 61(7):1058-67. PubMed ID: 22253482
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice.
    Harley IT; Stankiewicz TE; Giles DA; Softic S; Flick LM; Cappelletti M; Sheridan R; Xanthakos SA; Steinbrecher KA; Sartor RB; Kohli R; Karp CL; Divanovic S
    Hepatology; 2014 May; 59(5):1830-9. PubMed ID: 24115079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice.
    Giles DA; Ramkhelawon B; Donelan EM; Stankiewicz TE; Hutchison SB; Mukherjee R; Cappelletti M; Karns R; Karp CL; Moore KJ; Divanovic S
    Mol Metab; 2016 Nov; 5(11):1121-1130. PubMed ID: 27818938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
    Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
    Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Krill Oil Supplementation Reduces Exacerbated Hepatic Steatosis Induced by Thermoneutral Housing in Mice with Diet-Induced Obesity.
    Sistilli G; Kalendova V; Cajka T; Irodenko I; Bardova K; Oseeva M; Zacek P; Kroupova P; Horakova O; Lackner K; Gastaldelli A; Kuda O; Kopecky J; Rossmeisl M
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33572810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.